Annett Helcita Dsouza

Mrs. Annett Helcita Dsouza


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2024 in Viruses
Verified
Journal Article
Open access
PDF file
Vinayagamurthy BalamuruganVinayagamurthy Balamurugan
Vinayagamurthy Balamurugan
Rakshit OjhaRakshit Ojha
Rakshit Ojha
Kirubakaran Vinod KumarKirubakaran Vinod Kumar
Kirubakaran Vinod Kumar
AAAnand Asha
Anand Asha
SUHAIL ASHRAFSUHAIL ASHRAF
SUHAIL ASHRAF
BGBaldev Raj Gulati
Baldev Raj Gulati
Peste des petits ruminants (PPR) presents economic challenges in enzootic countries impacting small ruminant productivity. The state of Karnataka, India, implemented a mass vaccination campaign in alignment with the PPR-Global Eradication Programme (GEP) and the National Strategic Plan for PPR eradication. This study was conducted from January to March 2023 to assess seroconversion in post-vaccinated goats and sheep at the epidemiological unit (epi-unit) level, aligning with the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) guidelines in the PPR Global Control and Eradication Strategy (GCES). Before vaccination, 3466 random serum samples were collected from small ruminants of three age groups (6–12 months, 1–2 years, and >2 years) across 116 epi-units, spanning 82 taluks in 28 districts. Post-vaccination sero-monitoring included 1102 serum samples collected from small ruminants of the 6–12-month age group only, across 111 epi-units covering 64 taluks in 23 districts. The PPRV antibody status was determined using an indigenous hemagglutinin (H) protein monoclonal antibody-based competitive ELISA kit. Pre-vaccination, the PPR seropositivity rates were 55%, 62%, and 66% in the age groups of 6–12 months, 1–2 years, and >2 years, respectively, with a 61% PPRV antibody prevalence across all the age groups. Notably, 41% of the epi-units exhibited antibody prevalence rates of ≥70%, indicating a substantial population immunity, possibly attributed to the previous vaccination program in the state since 2011. In contrast, only 17% of the epi-units had below 30% seroprevalence rates, emphasizing the need for intensified vaccination. Statistical analysis of the data revealed significant correlations (p < 0.05) between the presence of PPRV antibodies and host factors such as species, breed, and sex. Post-vaccination seroprevalence in the 6–12 months age group was found to be 73.4%, indicating the use of an efficacious vaccine. On the evaluation of vaccination immunity in the 6–12 months age group, it was revealed that over 69% of the epi-units achieved a response surpassing ≥70%, indicating a significant improvement from 42% of the epi-units in pre-vaccination. For active PPR eradication, a mass vaccination campaign (>95% coverage) targeting small ruminant populations aged >4 months is advocated, aiming to achieve the desired herd immunity of >80%. This study offers crucial insights into PPR baseline seroprevalence/immunity status and vaccine efficacy, guiding national strategies towards a PPR-free India and further supporting the global eradication initiative.

30 July 2026 in Viruses
Verified
Journal Article
Open access
PDF file
Kirubakaran Vinod KumarKirubakaran Vinod Kumar
Kirubakaran Vinod Kumar
Rakshit OjhaRakshit Ojha
Rakshit Ojha
RDRamachandra Deshpande
Ramachandra Deshpande
SPShweta Priya
Shweta Priya
AGAkshatha Lokanath Goudar
Akshatha Lokanath Goudar
Vinayagamurthy BalamuruganVinayagamurthy Balamurugan
Vinayagamurthy Balamurugan
This study evaluated population immunity against peste des petits ruminants (PPR) in sheep and goats in India following the second annual round of mass vaccination conducted under the National PPR Eradication Programme (PPR EP), launched in 2023 in accordance with the national strategic plan. A cross-sectional post-vaccination evaluation (PVE) was conducted during August 2024 and April 2026 to assess the herd or population immunity under field conditions, in line with the WOAH and FAO Global Control and Eradication Strategy (GCES) of the PPR Global Eradication Programme (PPR GEP) 2030. A total of 52,133 serum samples were collected within 90 days post vaccination from sheep and goats across three age groups, 6–12 months (n = 18,002), 1–2 years (n = 17,316), and >2 years (n = 16,842), representing 1666 epidemiological units across multiple taluks and districts in 20 Indian states and Union Territories. Serum samples were tested for antibodies against PPR virus using in-house IVRI developed hemagglutinin (H) protein monoclonal antibody based competitive ELISA. The study revealed an overall population immunity of 72%, with age-wise PPRV antibody prevalence of 70.8%, 71.8%, and 72.6% in the 6–12-month, 1–2-year, and >2-year age groups, respectively. Statistical analysis showed significant associations (p < 0.005) between PPRV seropositivity and host factors, including species. Population immunity increased markedly from 41% (pre-vaccination sero-prevalence) in 2023 to nearly 72% by 2025-26 following two consecutive rounds of annual vaccination, accompanied by a substantial reduction in confirmed outbreaks from 57 during 2023 to 20 in 2025 in these 20 states/Union Territories. Notably, about 14.5% of epidemiological units remained below 30% seroprevalence, indicating targeted gaps requiring intensified vaccination. Overall animal vaccination coverage exceeded 95% among small ruminants aged above four months, approaching the population immunity threshold of 70 to 80%. These findings highlight the critical role of sustained successive mass vaccination campaigns in achieving and maintaining protective herd/population immunity, thereby supporting national and global PPR eradication goals.

6 October 2026 in Viruses
Verified
Journal Article
Open access
PDF file
Vinayagamurthy BalamuruganVinayagamurthy Balamurugan
Vinayagamurthy Balamurugan
Kirubakaran Vinod KumarKirubakaran Vinod Kumar
Kirubakaran Vinod Kumar
Rakshit OjhaRakshit Ojha
Rakshit Ojha
PMPonnidurai Malini
Ponnidurai Malini
RDRamachandra Deshpande
Ramachandra Deshpande
Satya ParidaSatya Parida
Satya Parida
India launched a nationwide Peste des Petits Ruminants (PPR) Eradication Programme in 2023 with the objective of achieving countrywide control and elimination of PPR by 2030, adapting a systematic mass vaccination, surveillance, and seromonitoring strategy in alignment with the WOAH/FAO Global Control and Eradication Strategy (GCES) under the PPR Global Eradication Programme (PPR-GEP) 2030. As part of the first round of mass vaccination, the present study evaluates the effectiveness of the PPR Sungri-96 (Lineage IV) vaccine in sheep and goats in fields across all the states in India, with particular emphasis on the post-vaccination evaluation (PVE) as per WOAH guidelines. A total of 24,542 post-vaccination (30–90 days) serum samples were collected from sheep and goats aged 6–12 months from 2528 epidemiological units (epi-units, villages) across 24 states of India, following GCES guidelines. Sampling was conducted according to state vaccination schedules during January 2023–December 2024, ensuring appropriate post-vaccination immune-response windows. Serum samples were analysed to detect PPR virus (PPRV)-specific antibodies using the native PPR competitive ELISA (c-ELISA) kit. The study demonstrated an overall post-vaccination seroconversion rate of 69.3% (95% CI: 68.7–69.8%) among small ruminants, indicating a substantial vaccine-induced immune response under field conditions in the target age group with desirable vaccine effectiveness. Exceptionally high post-vaccination seroconversion was observed in Telangana (91.6%) and Andhra Pradesh (82.3%), reflecting effective implementation of vaccination campaigns in these two states. Overall, 61% (1553/2528) of the evaluated epi-units recorded 70% seroconversion post vaccination, whereas 22% (510/2287) of epi-units showed ≥70% seroprevalence pre vaccination in sheep and goats aged 6 to 12 months. These findings demonstrate the effectiveness of the PPR Sungri-96 vaccine in inducing protective immunity under field conditions in accordance with GCES guidelines. The observed inter-state variations in immune response may be attributed to differences in vaccination coverage, implementation efficiency, animal demographics, husbandry practices, and local epidemiological conditions. However, some states failed to achieve the desired level of post-vaccination immunity, indicating the need for intensified vaccination efforts and improved campaign implementation in such regions. Continued mass vaccination, strengthened surveillance, real-time disease monitoring, farmer awareness programs, and capacity-building initiatives for veterinary services are critical for improving vaccine effectiveness and accelerating progress towards a PPR-free India. This study provides important field evidence supporting the effectiveness of the PPR Sungri-96 vaccine and contributes significantly to both national and global PPR eradication initiatives.